NCT04410731View on ClinicalTrials.gov

Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

March 15, 2024

Study Completion Date

March 15, 2024

Conditions
Facet-Mediated Low Back Pain
Interventions
DRUG

Single bilateral intra-articular injection of allogeneic BM-MSCs for lumbar facet joint arthropathy

Single bilateral intra-articular injection of manufactured cell cultured expanded allogeneic BM-MSCs for painful lumbar facet joint arthropathy

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER